Larimar Therapeutics, Inc. LRMR
2.36 USD -0.40 (-14.67%)
Nov 5, 2026, 3:55 PM EST
2.27 Day range 2.83
1.92 52-week range 6.42
- YTD
- -38.19%
- 1 year
- -26.86%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -172.50M | -90.89M | -41.76M | -36.53M | -50.47M | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 86.02M | 33.82M | 28.09M | 28.16M | 71.44M | |
| 145.84M | 200.22M | 95.94M | 126.41M | 78.67M | |
| 67.76M | 28.41M | 14.21M | 15.50M | 14.25M | |
| 4.07M | 5.12M | 5.55M | 5.41M | 6.00M | |
| 78.08M | 171.81M | 81.72M | 110.90M | 64.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -113.20M | -70.76M | -33.46M | -27.57M | -42.10M | |
| 100.31M | -85.39M | 33.35M | -90.96M | 24.17M | |
| 65.09M | 161.88M | 30.00K | 75.26M | 19.89M | |
| -91.00K | -515.00K | -164.00K | -100.00K | -333.00K | |
| 52.19M | 5.74M | -76.00K | -43.27M | 1.95M |